Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Thurmond

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
IEEE Transactions on Visualization and Computer Graphics|November 8, 2008
The seismic analyzer: interpreting and illustrating 2D seismic dataDaniel Patel, Christopher Giertsen, John Thurmond, et al.
Human Molecular Genetics|November 10, 2009
Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyMatthew E R Butchbach, Jasbir Singh, Margrét Thorsteinsdóttir, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Design and synthesis of potent, orally active, inhibitors of carboxypeptidase U (TAFIa)Magnus O Polla, Louise Tottie, Carita Nordén, et al.
ACS Chemical Biology|October 9, 2008
DcpS as a therapeutic target for spinal muscular atrophyJasbir Singh, Michael Salcius, Shin-Wu Liu, et al.
Journal of Medicinal Chemistry|January 22, 2008
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophyJohn Thurmond, Matthew E R Butchbach, Marty Palomo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
IEEE Transactions on Visualization and Computer Graphics|November 8, 2008
The seismic analyzer: interpreting and illustrating 2D seismic dataDaniel Patel, Christopher Giertsen, John Thurmond, et al.
Human Molecular Genetics|November 10, 2009
Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyMatthew E R Butchbach, Jasbir Singh, Margrét Thorsteinsdóttir, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Design and synthesis of potent, orally active, inhibitors of carboxypeptidase U (TAFIa)Magnus O Polla, Louise Tottie, Carita Nordén, et al.
ACS Chemical Biology|October 9, 2008
DcpS as a therapeutic target for spinal muscular atrophyJasbir Singh, Michael Salcius, Shin-Wu Liu, et al.
Journal of Medicinal Chemistry|January 22, 2008
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophyJohn Thurmond, Matthew E R Butchbach, Marty Palomo, et al.
Pageof 1